OBAGI- arbutin cream 
YS PLUS CORPORATION

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Drug Facts

Ingredients: Water, Glycerin, Cetyl Alcohol, Arbutin, PPG-2 Myristyl Ether Propionate,

Sodium Lauryl Sulfate, TEA_Salicylate, Tocopheryl Acetate, Ascorbic Acid, Lactic Acid,

Phenyl Trimethicone, Sodium Metabisulfite, BHT, Saponins, Disodium EDTA,

Methylparaben, Propylparaben

BLENDfx is a brightening cream specially formulated with Arbutin, antioxidants

and emullient to help clarify and brighten skin

DIRECTIONS:  Apply to affected area twice daily or as

directed by a physician

WARNINGS: Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions

including anaphylactic symptoms and life-threatening or less severe asthmatic episodes

in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population

is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in

nonasthmatic people.

WARNING: Keep out of reach of children

Store at controlled room temperature

15 C - 30 C (59 F - 86 F)

Arbutin 4.03 mg in 57 g

BLENDfx is a brightening cream specially formulated with Arbuton, antioxidants and

emullients to help clarify and brighten skin

copy of label
OBAGI 
arbutin cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69269-830
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ARBUTIN (UNII: C5INA23HXF) (ARBUTIN - UNII:C5INA23HXF) ARBUTIN4.03 mg  in 57 g
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
GLYCERIN (UNII: PDC6A3C0OX)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
PPG-2 MYRISTYL ETHER PROPIONATE (UNII: 88R97D8U8A)  
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
TROLAMINE SALICYLATE (UNII: H8O4040BHD)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
ASCORBIC ACID (UNII: PQ6CK8PD0R)  
LACTIC ACID, UNSPECIFIED FORM (UNII: 33X04XA5AT)  
PHENYL TRIMETHICONE (UNII: DR0K5NOJ4R)  
SODIUM DITHIONATE (UNII: RPF7Z41GAW)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69269-830-0157 g in 1 BOTTLE; Type 0: Not a Combination Product10/01/201412/31/2015
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other10/01/201412/31/2015
Labeler - YS PLUS CORPORATION (843007597)

Revised: 6/2017
 
YS PLUS CORPORATION